Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 632.00
Bid: 618.00
Ask: 636.00
Change: 0.00 (0.00%)
Spread: 18.00 (2.913%)
Open: 632.00
High: 0.00
Low: 0.00
Prev. Close: 632.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

18 Jun 2019 17:15

RNS Number : 6737C
Intl. Biotechnology Trust PLC
18 June 2019
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

International Biotechnology Trust plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Lazard Asset Management LLC

City and country of registered office (if applicable)

New York, United States of America

4. Full name of shareholder(s) (if different from 3.)v

Name

Mellon Trust

Northern Trust Co.

State Street Bank- Master Tr - ETC

State Street Bank-Custody Master Trust

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

17 June 2019

6. Date on which issuer notified (DD/MM/YYYY):

18/06/2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4.954%

N/A

4.954%

38,202,663

Position of previous notification (if

applicable)

9.990%

N/A

9.990%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0004559349

1,892,588

4.954%

SUBTOTAL 8. A

1,892,588

4.954%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Lazard Asset Management LLC

4.954%

 

4.954%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Contact name: Legal & Compliance Department

Contact telephone number: 0207 448 2085

 

Place of completion

Lazard Asset Management Limited

Date of completion

18 June 2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUWANRKUANAAR
Date   Source Headline
15th Mar 20235:12 pmRNSTransaction in Own Shares
15th Mar 20234:24 pmRNSTransaction in Own Shares
13th Mar 20234:10 pmRNSTransaction in Own Shares
13th Mar 202312:32 pmRNSPortfolio Update
7th Mar 20234:59 pmRNSTransaction in Own Shares
2nd Mar 20235:29 pmRNSTransaction in Own Shares
21st Feb 20237:00 amRNSPortfolio Update
13th Feb 20237:00 amRNSInvestment Management Update
7th Feb 20239:00 amRNSDirector Declaration
2nd Feb 20237:00 amRNSPortfolio Update
23rd Jan 20235:22 pmRNSAppointment of Non-executive Director
23rd Jan 20237:00 amRNSPortfolio Update
3rd Jan 20237:00 amRNSBlock listing Interim Review
19th Dec 20229:00 amRNSPortfolio Update
14th Dec 20227:00 amRNSPortfolio Update
12th Dec 20222:23 pmRNSPortfolio Update
8th Dec 20227:47 amEQSHardman & Co Research on International Biotechnology Trust (IBT): Low FDA activity may drive further M&A
6th Dec 20224:24 pmRNSDividend Declaration
6th Dec 20224:18 pmRNSResult of AGM
1st Dec 20222:38 pmRNSTotal Voting Rights
17th Nov 20228:00 amRNSPortfolio Update
9th Nov 20224:48 pmRNSTransaction in Own Shares
8th Nov 20224:41 pmRNSTransaction in Own Shares
7th Nov 20225:20 pmRNSTransaction in Own Shares
4th Nov 20224:40 pmRNSTransaction in Own Shares
3rd Nov 20224:57 pmRNSTransaction in Own Shares
1st Nov 20225:22 pmRNSTransaction in Own Shares
1st Nov 202211:26 amRNSTotal Voting Rights
1st Nov 20227:00 amRNSAnnual Financial Report
31st Oct 20225:20 pmRNSTransaction in Own Shares
27th Oct 20225:33 pmRNSTransaction in Own Shares
26th Oct 20224:39 pmRNSTransaction in Own Shares
25th Oct 20228:00 amRNSPortfolio Update
24th Oct 20225:12 pmRNSTransaction in Own Shares
18th Oct 20225:36 pmRNSTransaction in Own Shares
17th Oct 20221:16 pmRNSTransaction in Own Shares
13th Oct 20225:55 pmRNSTransaction in Own Shares
13th Oct 20227:00 amRNSKepler Trust Intelligence: New Research
3rd Oct 202212:07 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSCompliance with the Market Abuse Regulation
20th Sep 20225:22 pmRNSTransaction in Own Shares
20th Sep 20228:00 amRNSPortfolio Update
25th Aug 20228:30 amRNSPortfolio Update
1st Aug 202211:12 amRNSTotal Voting Rights
22nd Jul 20223:29 pmRNSDividend Declaration
20th Jul 20229:00 amRNSPortfolio Update
11th Jul 20221:26 pmRNSReplacement: Transaction in Own Shares
7th Jul 20225:45 pmRNSTransaction in Own Shares
6th Jul 20225:16 pmRNSTransaction in Own Shares
1st Jul 20225:40 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.